Acker F, Chromik J, Tiedjen E, Wolf S, et al. Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy. Eur J Haematol 2024 Jul 18. doi: 10.1111/ejh.14278.
PMID: 39023132